How can research inform the development of evidence-based approaches to improving the quality of life for patients with serious illnesses?

"Re: A Prospective, Randomized, Placebo Controlled, Double-Blind Study of Pelvic Electromagnetic Therapy for the Treatment of Chronic Pelvic Pain Syndrome ... The safety/tolerability of clopidogrel (plus aspirin) is superior to that of ticlopidine (plus aspirin) (P=0.005). The 300-mg loading dose was well tolerated. Prospective Double-blind-study of Supplementary Antibiotic-therapy for Duodenal-ulcer Associated with Campylobacter Pyloridis Infection. American Journal of ... Jan 22, 2021 ... The aim of this randomized, double-blind phase II/III study was to assess the efficacy of axitinib in patients with advanced G1-2 extra-pancreatic NETs. A decentralized, Phase 2, randomized, double-blind study of Nirmatrelvir/Ritonavir compared with placebo/Ritonavir for long COVID. A Phase 3, randomized, double-blind, study evaluating efficacy and safety of riliprubart versus intravenous immunoglobulin (IVIg) in participants with chronic ... A RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS SERUM TRANSAMINASE ELEVATIONS AND ANTIBODY FORMATION FOLLOWING REPEAT SUBCUTANEOUS DOSING OF LMWH, UFH OR THE ... Feb 21, 1980 ... Controlled Double-Blind Study of the Effect of Rifampin on Humoral and Cellular Immune Responses in Patients with Pulmonary Tuberculosis and ... Upon receipt of the test material, researchers will record the date of receipt on their copy of DEA Form 222, or attach the documentation to their retained Copy ... In a double-blind study, neither the patients nor the researchers/doctors know which study group the patients are in. In a triple-blind study, the patients ...